文献速递类风湿关节炎

甲氨蝶呤暂停一周与两周对类风湿关节炎患者季节性流感疫苗接种影响的多中心、前瞻性、随机、平行组试验

A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2022-12-07

本多中心前瞻性随机平行组非劣效试验纳入接受稳定剂量甲氨蝶呤的类风湿关节炎患者,随机分为疫苗接种后暂停甲氨蝶呤1周组(90例)或2周组(88例),比较四价2021-2022季节性流感疫苗接种后4周满意疫苗应答比例,结果显示1周组与2周组满意应答比例无显著差异(68.9% vs 75.0%,P=0.364),1周暂停非劣效于2周暂停。

要点

  • 接种后暂停甲氨蝶呤1周与2周的满意疫苗应答比例分别为68.9%与75.0%,组间无显著差异(P=0.364)。
  • 两组对4种流感抗原的血清保护率及抗体滴度倍数增长均相似。
  • 在稳定剂量甲氨蝶呤治疗的类风湿关节炎患者中,接种后暂停1周对诱导满意疫苗应答非劣效于暂停2周。

核心结论

  • 在稳定剂量甲氨蝶呤治疗的类风湿关节炎患者中,季节性流感疫苗接种后暂停甲氨蝶呤1周对诱导满意疫苗应答非劣效于暂停2周。

研究设计与样本

  • 多中心、前瞻性、随机、平行组非劣效试验,接受稳定剂量甲氨蝶呤的类风湿关节炎患者按1:1随机分配至疫苗接种后暂停甲氨蝶呤1周组或2周组。
  • 患者接种含H1N1、H3N2、B/Yamagata和B/Victoria株的四价2021-2022季节性流感疫苗。
  • 改良意向治疗人群包括1周暂停组90例和2周暂停组88例;平均±标准差甲氨蝶呤剂量分别为12.6±3.4 mg/周和12.9±3.3 mg/周。

主要发现

  • 主要结局满意疫苗应答(接种后4周血凝抑制试验抗体滴度对4种疫苗株中至少2种达到≥4倍增长)比例1周暂停组为68.9%,2周暂停组为75.0%,组间无显著差异(P=0.364)。
  • 两组对4种流感抗原的血清保护率和抗体滴度倍数增长均相似。

关键数值与推荐

  • 满意疫苗应答定义为接种后4周血凝抑制试验抗体滴度对4种疫苗株中至少2种达到≥4倍增长。
  • 1周暂停组满意疫苗应答比例68.9% vs 2周暂停组75.0%(P=0.364)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This clinical trial was conducted to investigate whether discontinuing methotrexate (MTX) for 1 week after seasonal influenza vaccination is noninferior to discontinuing for 2 weeks after vaccination in patients with rheumatoid arthritis (RA). METHODS: In this multicenter, prospective, randomized, parallel-group noninferiority trial, RA patients receiving a stable dose of MTX were randomly assigned at a ratio of 1:1 to discontinue MTX for 1 week or for 2 weeks after they received the quadrivalent 2021-2022 seasonal influenza vaccine containing H1N1, H3N2, B/Yamagata, and B/Victoria strains. The primary outcome measure was the proportion of patients with a satisfactory vaccine response, which was defined as ≥4-fold increase in antibody titers, as determined with the hemagglutination inhibition assay, against ≥2 of the 4 vaccine strains at 4 weeks after vaccination. RESULTS: The modified intent-to-treat population included 90 patients in the 1-week MTX hold group and 88 patients in the 2-week MTX hold group. The mean ± SD MTX doses were 12.6 ± 3.4 mg/week in the 1-week MTX hold group and 12.9 ± 3.3 mg/week in the 2-week MTX hold group. The proportion of satisfactory vaccine responses did not differ between the groups (68.9% versus 75.0%; P = 0.364). The rate of seroprotection and the fold increase in antibody titers for each of the 4 influenza antigens were similar between the groups. CONCLUSION: A temporary discontinuation of MTX for 1 week after vaccination was noninferior to a discontinuation of MTX for 2 weeks after vaccination, regarding induction of a satisfactory vaccine response to a seasonal influenza vaccine in patients with RA receiving a stable dose of MTX.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Park JK, Lee YJ, Shin K, et al. A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2022. PMID: 35930728. doi:10.1002/art.42318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。